1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow RCC: new trials by email Literature Review of RCC trials Research Report on RCC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Study of Anlotinib Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma（RCC） Anlotinib, Sunitinib maleate - Anlotinib, RCC | Phase 2 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 133 | 2013-12-01 | 2016-04-26 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1)
China (1)